Cholinesterase inhibitors for Alzheimer's disease.
New cholinesterase inhibitors capable of slowing the progression of Alzheimer's disease are being introduced at a rapid pace. In prescribing these drugs and setting realistic expectations for outcome, it is necessary to understand that they affect cholinergic activity in other tissues as well as the brain. They may be most effective when used in combination with other drugs.
Stahl
S M
SM
Department of Psychiatry, University of California, San Diego, School of Medicine, USA.
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D002799:Cholinergic Fibers / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D013997:Time Factors
D002800:Cholinesterase Inhibitors